Normoxys Inc

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website

Established in 1985, Concurrent Technologies designs and develops high performance single board computer products for VME and CompactPCI open systems using the Intel Pentium and Freescale PowerPC processor families. Its products are used extensively in defense, telecommunications, industrial, scientific and transportation applications. The company s products are also used in medical and aerospace applications. Concurrent Technologies headquarters is in Colchester, England. Its North American office is in Ann Arbor, Mich.